Sponsored by:

Molecular Imaging: Page 432

NST is cleared for ApoSense trials
By AuntMinnie.com staff writers
NeuroSurvival Technologies (NST) has received the go-ahead from the U.S. Food and Drug Administration to begin clinical trials of ApoSense.
July 24, 2008
GE gets FDA nod for new PET/CT system
By AuntMinnie.com staff writers
GE Healthcare has received U.S. Food and Drug Administration clearance for a new PET/CT scanner.
July 23, 2008
FluoroPharma touts phase I tracer trial
By AuntMinnie.com staff writers
Imaging agent developer FluoroPharma has received positive phase I clinical trial results for its myocardial perfusion imaging tracer.
July 22, 2008
SNM draft report shows U.S. Mo-99 production years away
By Wayne Forrest
There are no quick fixes to the manufacture of medical radioisotopes in the U.S. to ensure an adequate supply of molybdenum-99 (Mo-99) in the future. A preliminary draft report has found that U.S. production and supply of Mo-99 is several years away and would require significant investment and regulatory approvals.
July 21, 2008
Cannavo on the future of PACS; SNM on isotope crisis
By Brian Casey
July 21, 2008
Eczacıbaşı Pharmaceuticals buys half of Monrol
By AuntMinnie.com staff writers
Eczacıbaşı Pharmaceuticals Manufacturing of Istanbul has acquired half of Monrol Nuclear Products of Kocaeli, Turkey.
July 17, 2008
MDS plans restructuring
By AuntMinnie.com staff writers
Canadian healthcare company MDS is restructuring in an effort to increase profitability at MDS Pharma Services and MDS Analytical Technologies.
July 17, 2008
PET/CT saves money; GE Healthcare taps new chief
By Brian Casey
July 16, 2008
PET procedures grow as sales fall
By AuntMinnie.com staff writers
PET procedure volume is growing at a double-digit rate in the U.S. and internationally, although new sales of the systems are falling in the U.S. compared to previous years.
July 16, 2008
PET/CT saves money compared to CT in stem cell transplant patients
By Wayne Forrest
Healthcare providers in the U.S. can save approximately $150 million a year by using FDG-PET/CT, rather than CT, to more accurately identify patients who will benefit from autologous stem cell transplant, also known as a bone marrow transplant.
July 16, 2008
Dilon nets Amerinet deal
By AuntMinnie.com staff writers
Scintimammography developer Dilon Technologies has received a three-year agreement from group purchasing organization Amerinet.
July 15, 2008
Monrol to open PET facility in Dubai
By AuntMinnie.com staff writers
Turkish radiopharmaceutical producer Monrol plans to open a PET radiopharmaceutical production facility in Dubai, United Arab Emirates, early next year.
July 15, 2008
Previous Page
Page 432 of 615
Next Page